Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

yahoo.com - Faheem Tahir - Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion
Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion
Yahoo!

Merck & Co., Inc. (NYSE: MRK) is included in our list of the best stocks to buy for financial stability. On March 25, 2026, Merck & Co., Inc. (NYSE:MRK) came into the limelight when Reuters reported that the company had agreed to buy Terns Pharma…

afr.com - Michael Smith - Pharma giants slam 'appalling' postcode lottery for weight loss drugs
Pharma giants slam 'appalling' postcode lottery for weight loss drugs
Australian Financial Review

Global pharmaceutical giants stepped up pressure on the Albanese government to subsidise weight-loss drugs, releasing data showing people in Sydney's west and regional areas are 34 per cent less likely to buy the medicines than affluent city…

marketbeat.com - Eastern Bank Acquires 263,867 Shares of Royalty Pharma PLC $RPRX
Eastern Bank Acquires 263,867 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Eastern Bank lifted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 71.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 635,122 shares of…

marketbeat.com - Urogen Pharma $URGN Shares Acquired by JPMorgan Chase & Co.
Urogen Pharma $URGN Shares Acquired by JPMorgan Chase & Co.
MarketBeat

JPMorgan Chase & Co. raised its stake in shares of Urogen Pharma (NASDAQ:URGN - Free Report) by 36.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 534,545…

cnbc.com - Evelyn Cheng - Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
CNBC

Hong Kong-listed Insilico Medicine has reached a deal with U.S. pharma giant Eli Lilly for AI-discovered drugs. The two companies have worked together since 2023. Insilico's CEO, Alex Zhavoronkov, said Eli Lilly has a competitive edge in certain…

marketbeat.com - Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Sees Large Decline in Short Interest
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Sees Large Decline in Short Interest
MarketBeat

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) was the target of a large decrease in short interest in March. As of March 13th, there was short interest totaling 76,183 shares, a decrease of 23.2% from the February 26th total of…

mediabistro.com - Media News - New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)
Mediabistro

The show also broadcasts across MENA and Latin America as sponsored programming. New to The Street, one of the fastest-growing financial media platforms in the United States, today announced the nationwide broadcast of Show #740, airing on…

fool.com - Thomas Niel - 1 Reason This Biotech Stock Could Triple Before Year-End
1 Reason This Biotech Stock Could Triple Before Year-End
The Motley Fool

When you think of GLP-1s and investing, the two large pharmaceutical companies benefiting most from this trend may first come to mind. First, there's Novo Nordisk, the first to bring GLP-1 weight loss drugs to market, with Ozempic and Wegovy.

thehindubusinessline.com - Crude oil shock deepens market jitters as Hormuz crisis hits India's macro outlook
Crude oil shock deepens market jitters as Hormuz crisis hits India's macro outlook
BusinessLine

Equity markets are grappling with a deepening correction as a geopolitical shock in West Asia morphs into a full-blown oil-driven macro risk. What began as a sentiment-led sell-off has now evolved into a tangible supply disruption, with tanker…

dailymail.co.uk - John Lee - 20 years for a cycle path? All we get is excuses, not infrastructure
20 years for a cycle path? All we get is excuses, not infrastructure
Mail Online

There is an innovative and fervently awaited greenway project near where I live that has been inexplicably delayed for years now. When I say the delays are inexplicable, the many State agencies who take some – never all – the…

redstate.com - Jennifer Oliver O'Connell - CPAC 2026: NIH Jay Bhattacharya: 'It's No Longer Tony Fauci's NIH
CPAC 2026: NIH Jay Bhattacharya: 'It's No Longer Tony Fauci's NIH
redstate.com

Director of the National Institutes of Health (NIH) and Acting Director of the Centers for Disease Control and Prevention (CDC) Jay Bhattacharya took to the CPAC stage to declare, 'It's no longer Tony Fauci's NIH.' Dr. Bhattacharya's remarks…

thehindubusinessline.com - Blackstone-backed EPL, Indovida to merge to create $2 bn packaging firm
Blackstone-backed EPL, Indovida to merge to create $2 bn packaging firm
BusinessLine

Blackstone-backed packaging firm EPL Ltd and Indorama Ventures' Indovida India, have signed definitive agreements to merge, in a deal that will create a $1-billion revenue consumer packaging platform focused on emerging markets, with a combined…

redstate.com - Jennifer Oliver O'Connell - CPAC 2026: HHS Secretary Robert F. Kennedy Jr. Talks the MAHA Agenda One Year In
CPAC 2026: HHS Secretary Robert F. Kennedy Jr. Talks the MAHA Agenda One Year In
redstate.com

Health and Human Services Secretary Robert Kennedy Jr. was greeted by cheers and ovations as he closed out CPAC 2026. As one of the most popular Cabinet officials, he offered insight into what a year of initiatives and programs geared to Make…

marketbeat.com - Eli Lilly and Company $LLY Shares Acquired by World Investment Advisors
Eli Lilly and Company $LLY Shares Acquired by World Investment Advisors
MarketBeat

World Investment Advisors increased its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 17.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned…

marketbeat.com - Synergy Asset Management LLC Sells 50,043 Shares of Eli Lilly and Company $LLY
Synergy Asset Management LLC Sells 50,043 Shares of Eli Lilly and Company $LLY
MarketBeat

Synergy Asset Management LLC cut its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 92.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm…

Receive a Daily briefing on Pharma Industry News

Get Started